Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Recent Patents on Anti-Cancer Drug Discovery
|
February 23, 2018
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied
Silvia M Ferrari, Ilaria Ruffilli, Marco Centanni, et al.
Immunologic Research
|
January 9, 2019
The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results
Poupak Fallahi, Silvia Martina Ferrari, Simona Piaggi, et al.
Journal of Clinical & Translational Endocrinology
|
June 14, 2019
Chemokines in hyperthyroidism
Silvia Martina Ferrari, Ilaria Ruffilli, Giusy Elia, et al.
Cancer Management and Research
|
November 6, 2019
Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 16, 2011
High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10
Alessandro Antonelli, Clodoveo Ferri, Silvia Martina Ferrari, et al.
Expert Review of Endocrinology & Metabolism
|
July 31, 2018
Novel treatment options for anaplastic thyroid cancer
Poupak Fallahi, Ilaria Ruffilli, Giusy Elia, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
January 28, 2020
New insight in endocrine-related adverse events associated to immune checkpoint blockade
Giusy Elia, Silvia Martina Ferrari, Maria Rosaria Galdiero, et al.
The Journal of Rheumatology
|
July 5, 2011
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ
Alessandro Antonelli, Clodoveo Ferri, Silvia Martina Ferrari, et al.
The Journal of Endocrinology
|
March 2, 2012
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy
Alessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 10, 2019
Novel therapies for thyroid autoimmune diseases: An update
Silvia Martina Ferrari, Poupak Fallahi, Giusy Elia, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Recent Patents on Anti-Cancer Drug Discovery
|
February 23, 2018
Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied
Silvia M Ferrari, Ilaria Ruffilli, Marco Centanni, et al.
Immunologic Research
|
January 9, 2019
The paramount role of cytokines and chemokines in papillary thyroid cancer: a review and experimental results
Poupak Fallahi, Silvia Martina Ferrari, Simona Piaggi, et al.
Journal of Clinical & Translational Endocrinology
|
June 14, 2019
Chemokines in hyperthyroidism
Silvia Martina Ferrari, Ilaria Ruffilli, Giusy Elia, et al.
Cancer Management and Research
|
November 6, 2019
Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
December 16, 2011
High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10
Alessandro Antonelli, Clodoveo Ferri, Silvia Martina Ferrari, et al.
Expert Review of Endocrinology & Metabolism
|
July 31, 2018
Novel treatment options for anaplastic thyroid cancer
Poupak Fallahi, Ilaria Ruffilli, Giusy Elia, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
January 28, 2020
New insight in endocrine-related adverse events associated to immune checkpoint blockade
Giusy Elia, Silvia Martina Ferrari, Maria Rosaria Galdiero, et al.
The Journal of Rheumatology
|
July 5, 2011
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ
Alessandro Antonelli, Clodoveo Ferri, Silvia Martina Ferrari, et al.
The Journal of Endocrinology
|
March 2, 2012
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy
Alessandro Antonelli, Silvia Martina Ferrari, Silvia Frascerra, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 10, 2019
Novel therapies for thyroid autoimmune diseases: An update
Silvia Martina Ferrari, Poupak Fallahi, Giusy Elia, et al.
Page
of 5